Novel approaches to new therapies for hepatitis B virus infection

Medicine & Life Sciences

• Hepatitis B 100%
• Chronic Hepatitis B 66%
• Molecular Targeted Therapy 28%
• Host Microbial Interactions 25%
• Life Cycle Stages 22%
• Hepatitis B virus 20%
• Genetic Therapy 19%
• Liver Diseases 17%
• Therapeutics 16%
• Hepatocellular Carcinoma 16%
• Vaccination 16%
• Fibrosis 15%
• Chronic Disease 15%
• Virus Diseases 15%
• Public Health 14%
• Morbidity 12%
• Liver 10%
• Mortality 10%